STOCK TITAN

TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

TransMedics Group, Inc. (TMDX) will release its third-quarter financial results on November 4, 2020, after market close. Following this, a conference call will be held at 4:30 p.m. ET. Investors can access the call by dialing (833) 378-1026 domestically or (236) 712-2500 internationally, using Conference ID: 1716957. TransMedics is a leader in organ transplant technologies, focusing on enhancing organ quality and increasing the utilization of donor organs for patients with end-stage organ failure.

Positive
  • None.
Negative
  • None.

ANDOVER, Mass., Oct. 21, 2020 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter after market close on Wednesday, November 4, 2020. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (833) 378-1026 for domestic callers or (236) 712-2500 for international callers, followed by Conference ID: 1716957. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-report-third-quarter-2020-financial-results-on-november-4-2020-301157334.html

SOURCE TransMedics, Inc.

FAQ

When will TransMedics report its third-quarter 2020 financial results?

TransMedics will report its third-quarter 2020 financial results on November 4, 2020, after market close.

What time is the conference call for TransMedics' financial results?

The conference call will take place at 4:30 p.m. ET on November 4, 2020.

How can I listen to the TransMedics conference call?

Investors can listen to the conference call by dialing (833) 378-1026 for domestic callers or (236) 712-2500 for international callers, using the Conference ID: 1716957.

Where can I find the webcast of the TransMedics conference call?

The live and archived webcast will be available on the 'Investors' section of the TransMedics website.

TransMedics Group, Inc.

NASDAQ:TMDX

TMDX Rankings

TMDX Latest News

TMDX Stock Data

2.52B
32.48M
3.18%
111.8%
25.11%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ANDOVER